Xometry (NASDAQ: XMTR) director lines up 5,000-share sale
Rhea-AI Filing Summary
Xometry, Inc. (XMTR) has a notice of proposed sale of securities filed under Rule 144 for shares of its Class A Common Stock. Director Katherine Weymouth, through UBS Financial Services Inc., indicates an intention to sell 5,000 shares of Class A Common Stock of Xometry.
The notice also lists a prior transaction during the past three months, showing a sale involving 5,000 shares of Xometry stock on 08/28/2026, with an associated value of 471500. The planned sale references a cashless exercise of options and trading on NASDAQ.
Positive
- None.
Negative
- None.
Key Figures
Shares proposed to be sold: 5,000 shares of Class A Common Stock
Shares sold during past 3 months: 5,000 shares
Value associated with past 3 months sale: 471500
+1 more
4 metrics
Shares proposed to be sold
5,000 shares of Class A Common Stock
Planned sale by Katherine Weymouth under Rule 144
Shares sold during past 3 months
5,000 shares
Transaction listed on 08/28/2026 in the past 3 months section
Value associated with past 3 months sale
471500
Amount shown beside 5,000 shares sold on 08/28/2026
Planned transaction date
08/31/2026
Date shown for securities to be sold and related entries
Key Terms
Rule 144, Cashless Exercise, attorney-in-fact, Class A Common, +1 more
5 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Cashless Exercise financial
"5000 | 08/31/2026 | Cashless Exercise"
A cashless exercise is a way for an option holder to convert stock options into actual shares without paying the purchase price in cash; instead they immediately give up a portion of the newly issued shares to cover the cost and any withholding taxes. Investors care because this process increases the number of shares available and can slightly dilute existing holdings, while also signaling how insiders or employees are realizing compensation without needing cash — similar to paying for a purchase by handing over part of what you just bought.
attorney-in-fact regulatory
"for UBS Financial Services Inc, as attorney-in-fact for Katherine"
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.
Class A Common financial
"144: Securities Information Class A Common | UBS Financial Services Inc"
NQO financial
"Class A Common | 08/31/2026 | NQO | Issuer"
FAQ
Who is the insider involved in the XMTR Form 144 filing?
The insider is Katherine Weymouth, identified as a Director of Xometry, Inc. The filing covers her proposed sale of Xometry Class A Common Stock under Rule 144 and notes that UBS Financial Services Inc. is the broker handling the transaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.